| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/06/2007 | US7186503 Compounds and methods for modulating activation of NF-κB |
| 03/06/2007 | CA2202228C Novel retinoids |
| 03/06/2007 | CA2189131C Use of pteridine derivatives as no-synthase inhibitors |
| 03/06/2007 | CA2150185C Pharmaceutical composition for the treatment of stoma-peripheral inflammation |
| 03/01/2007 | WO2007024944A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 03/01/2007 | WO2007024901A1 Cytokine modulators and related methods of use |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023273A1 Cell migration modulating compounds |
| 03/01/2007 | WO2007023143A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 03/01/2007 | WO2007023114A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | WO2007023105A1 FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS |
| 03/01/2007 | WO2007022937A1 Pyridazine derivatives with antiinflammatory activity |
| 03/01/2007 | WO2007022813A2 A METHOD FOR PREPARING A STABLE IMMUNOGENIC PRODUCT COMPRISING ANTIGENIC HETEROCOMPLEXES OF TNFα AND A CARRIER PROTEIN |
| 03/01/2007 | WO2007022774A1 THERAPEUTICALLY ACTIVE α-MSH ANALOGUES |
| 03/01/2007 | WO2007022642A2 Anti-inflammatory molecules and their uses |
| 03/01/2007 | WO2006125970A3 Phospholipids for use in the treatment of an allergic inflammatory condition |
| 03/01/2007 | WO2006086992A3 Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands |
| 03/01/2007 | WO2006081273A8 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 03/01/2007 | WO2006035244A9 Ecteinascidin compounds as anti -inflammatory agents |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049639 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases; reduced side effects; 13-hydroxy-DHA (13-hydroxy-DHA) |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 03/01/2007 | US20070049595 Autoimmune disease; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents; osteoporosis |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070049583 Benzoxazine and benzothiazine derivatives and their use in pharmaceutical agents |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070049516 Use of Insulin for the Treatment of Cartilaginous Disorders |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048390 Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases |
| 03/01/2007 | US20070048378 Nanoparticulate anticonvulsant and immunosuppressive compositions |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048305 CD147 binding molecules as therapeutics |
| 03/01/2007 | US20070048298 administering nucleoproteins such as retinoblastoma associated protein 48 suppressor or inhibitors, used for prophylaxis of Sjogren's syndrome, as diagnostic agents or screening antiapoptosic agents |
| 03/01/2007 | US20070048287 Molecular antigen array |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | DE10308864B4 Neues Brauverfahren, damit gebrautes Bier und dessen Verwendung New brewing process, thus brewed beer and its use |
| 03/01/2007 | CA2622904A1 Self-assembling nanoparticles for the treatment of vascular diseases |
| 03/01/2007 | CA2620257A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620228A1 Therapeutically active .alpha.-msh analogues |
| 03/01/2007 | CA2620173A1 Alpha2c adrenoreceptor agonists |
| 03/01/2007 | CA2620171A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 03/01/2007 | CA2620106A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620104A1 Fused pyrazole as p38 map kinase inhibitors |
| 03/01/2007 | CA2619038A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 03/01/2007 | CA2619037A1 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
| 03/01/2007 | CA2609948A1 Vasoactive kit and composition and uses thereof |
| 03/01/2007 | CA2609572A1 A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of tnf.alpha. and a carrier protein |
| 02/28/2007 | EP1757937A2 Antagonists of HMG1 for treating inflammatory conditions |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757619A2 Osteoprotegerin in milk |
| 02/28/2007 | EP1757602A1 Vla-4 inhibitor |
| 02/28/2007 | EP1757584A1 Heterocyclic substituted amides, their production and their use |
| 02/28/2007 | EP1757325A1 Use of botulinum toxin for treating myofascial pain |
| 02/28/2007 | EP1757321A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 02/28/2007 | EP1757289A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 02/28/2007 | EP1757281A2 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| 02/28/2007 | EP1756163A2 Method of treating granuloma annulare or sarcoid |
| 02/28/2007 | EP1756120A1 Purine derivative |
| 02/28/2007 | EP1756110A1 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR PRODUCTION THE ACTIVE AGENT |
| 02/28/2007 | EP1756108A2 Azaindoles useful as inhibitors of rock and other protein kinases |
| 02/28/2007 | EP1756102A1 8-PHENOXY-GammaCARBOLINE DERIVATIVES |
| 02/28/2007 | EP1756065A1 Anti-cytokine heterocyclic compounds |
| 02/28/2007 | EP1756043A1 Ortho substituted aryl or heteroaryl amide compounds |
| 02/28/2007 | EP1756042A1 Substituted methyl aryl or heteroaryl amide compounds |
| 02/28/2007 | EP1756032A1 Crth2 receptor antagonists |
| 02/28/2007 | EP1755678A2 Active substance combination of a carbinol compound and an opioid |
| 02/28/2007 | EP1755606A1 Quinazolinone derivatives useful as vanilloid antagonists |
| 02/28/2007 | EP1755604A2 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 02/28/2007 | EP1755603A2 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity |
| 02/28/2007 | EP1755565A2 Soft gelatin capsule comprising omega-3 polyunsaturated fatty acid |
| 02/28/2007 | EP1572179B1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 02/28/2007 | EP1551375B1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1482951B8 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| 02/28/2007 | EP1456197B1 Piperidine-2,6-diones that are heterocyclically substituted in position 3 |
| 02/28/2007 | EP1429807B1 Combination of a nsaid and a pde-4 inhibitor |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1392666B1 Biologically active methylene blue derivatives |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | EP1368094B1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a|-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1320541B1 Tgf-beta inhibitors and methods |
| 02/28/2007 | EP1309592B9 Substituted pyrazoles |
| 02/28/2007 | EP1272186B1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | EP0758390B1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/28/2007 | CN1922189A Spirocyclic cyclohexane derivatives with affinity for the ORL1-receptor |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922158A Isothiourea derivatives |
| 02/28/2007 | CN1922150A Indazole derivatives and pharmaceutical compositions containing them |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921883A Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders |
| 02/28/2007 | CN1921847A 氨基醇化合物 Amino alcohol compound |